Other languages Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
781,000 ^KRW	+0.77%		-2.62%	+2.76%

Apr. 25	Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	MT
Apr. 25	Samsung Biologics Posts Higher Q1 Profit, Sales	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	Apr. 25
Samsung Biologics Posts Higher Q1 Profit, Sales	Apr. 25
Samsung Biologics Boosts Contract Size with MSD Switzerland	Apr. 08
Samsung Life Science Fund Invests in Biologics Developer	Mar. 20
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	Mar. 12
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	Mar. 07
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	Mar. 07
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	Feb. 29
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	Feb. 09
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	Jan. 29
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	Jan. 29
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	Jan. 29
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	Jan. 29
Samsung Biologics's Q4 Net Income Declines	Jan. 24
Samsung Biologics Subsidiary Secures Ministry Approval for Soliris Biosimilar	Jan. 23
Samsung C&T Inks Deal with US-Based Flagship Pioneering for Bio Startup Investment	Jan. 09
South Korean shares fall for second day after US Fed minutes	Jan. 03
S.Korean shares fall after Fed minutes; biopharma leads declines	Jan. 04
S.Korean shares hit 19-month high on biopharma, e-commerce boost	Jan. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Other languages

Filters